Levodopa/Carbidopa

Prescription ·Strong evidence ·Reviewed May 2026

Levodopa/carbidopa is the gold-standard treatment for Parkinson's disease. Levodopa is the metabolic precursor to dopamine and crosses the blood-brain barrier, where it is converted to dopamine by aromatic L-amino acid decarboxylase. Carbidopa inhibits this enzyme peripherally, reducing nausea and increasing CNS levodopa availability. Nearly all Parkinson's patients will eventually require levodopa therapy.

What it's good for
  • Most effective medication for motor symptoms of Parkinson's disease
  • Improves bradykinesia, rigidity, and tremor
  • Rapid symptom relief
  • Available in multiple formulations (immediate, controlled, intestinal gel)
What to watch for
  • Nausea and vomiting (especially early in treatment)
  • Orthostatic hypotension
  • Dyskinesias (involuntary movements, with chronic use)
  • Concurrent use with non-selective MAO inhibitors (hypertensive crisis risk); MAO-B inhibitors are safe
  • Narrow-angle glaucoma

The bottom line

Evidence rating strong. Most-documented uses: most effective medication for motor symptoms of parkinson's disease, improves bradykinesia, rigidity, and tremor, rapid symptom relief. 10 sources indexed (2016–2025), with 6 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Levodopa is converted to dopamine in the CNS by DOPA decarboxylase, replenishing depleted dopamine in the striatum of patients with Parkinson's disease. Carbidopa inhibits peripheral DOPA decarboxylase, preventing premature conversion of levodopa to dopamine outside the brain, thereby increasing CNS bioavailability from ~1% to ~10% and reducing peripheral dopaminergic side effects (nausea, cardiovascular effects).1,2

Class
Dopaminergic / Antiparkinson
Absorption
Best on an empty stomach
Dosing

Dosing & protocol.

Common range
25/100 mg (carbidopa/levodopa) three times daily initially, titrated to 200-800 mg levodopa/day in divided doses (as prescribed by your physician)
Recommended form
Immediate-release tablets; controlled-release (Sinemet CR) for motor fluctuations; intestinal gel (Duopa) for advanced disease

Take on empty stomach 30-60 min before meals; protein can reduce absorption by competing for amino acid transporters in the gut and at the blood-brain barrier. Low-protein meals during the day may optimize 'on' time.9,10

Depletions

What it depletes.

Nutrients this medication can lower over time, and what to replace.

Vitamin B6

Moderate

Carbidopa can bind pyridoxal phosphate and reduce functional vitamin B6 availability during chronic levodopa-carbidopa therapy.

Replace Pyridoxine only with prescriber guidanceMonitor Plasma PLP + neurologic symptomsOnset Usually with high-dose or prolonged therapy

Vitamin B12

Mild

Levodopa methylation increases homocysteine burden, and low B12 status can worsen this metabolic effect during chronic therapy.

Replace MethylcobalaminMonitor Serum B12 + methylmalonic acid + homocysteineOnset Usually over months to years of therapy

Folate

Mild

Levodopa methylation can increase methyl-donor demand, making folate status clinically relevant when homocysteine rises on chronic therapy.

Replace Folate per clinician guidanceMonitor Serum folate or RBC folate + homocysteineOnset Usually over months to years of therapy
Safety

Full safety detail.

Side effects

  • Nausea and vomiting (especially early in treatment)
  • Orthostatic hypotension
  • Dyskinesias (involuntary movements, with chronic use)
  • Motor fluctuations ('wearing off' and 'on-off' phenomena)
  • Vivid dreams and hallucinations
  • Impulse control disorders (less common than dopamine agonists)
  • Darkening of urine and sweat

Contraindications

  • Concurrent use with non-selective MAO inhibitors (hypertensive crisis risk); MAO-B inhibitors are safe
  • Narrow-angle glaucoma
  • Known hypersensitivity to levodopa or carbidopa1,2
  • History of melanoma (theoretical concern, controversial)
Interactions

Interaction records.

SeriousTiming Sensitive

Iron

Iron chelates levodopa in the GI tract, forming insoluble complexes that significantly reduce levodopa absorption. This can worsen Parkinson's disease symptoms by reducing the amount of levodopa reaching the brain. Studies show iron can reduce levodopa bioavailability by up to 50%.

Recommendation: Separate levodopa/carbidopa and iron supplements by at least 2 hours. Take iron at a different time of day than your Parkinson's medication. Inform your neurologist about iron supplementation.

SeriousCaution

Vitamin B6

Vitamin B6 (pyridoxine) is a cofactor for DOPA decarboxylase, which converts levodopa to dopamine peripherally before it reaches the brain. While carbidopa blocks peripheral decarboxylation, high-dose B6 (>50mg/day) may partially overcome carbidopa's inhibition, reducing levodopa's efficacy.

Recommendation: Avoid high-dose vitamin B6 supplements (>50mg/day) while on levodopa/carbidopa. Standard multivitamin doses of B6 (2-10mg) are generally safe when carbidopa is included. If you need higher B6 doses, consult your neurologist.

ModerateCaution

5-HTP

5-HTP and levodopa may compete for the same amino acid transport systems (large neutral amino acid transporter) across the blood-brain barrier and for AADC enzyme activity. Additionally, increased central serotonin from 5-HTP may interact with dopaminergic pathways.

Recommendation: Use caution when combining 5-HTP with levodopa/carbidopa. If considering 5-HTP for mood support, discuss with your neurologist first. Monitor for changes in Parkinson's symptom control or emergence of new side effects.

ModerateTiming Sensitive

L-Tyrosine

L-tyrosine is a large neutral amino acid and can theoretically compete with levodopa for intestinal and blood-brain barrier transport when taken in large supplemental doses. A short trial of 1,000 mg/day tyrosine in people with Parkinson's disease receiving dopaminergic therapy was well tolerated, so the concern is mainly high-dose or poorly timed use. Taking tyrosine close to levodopa could still make motor response less predictable in protein-sensitive patients.

Recommendation: Do not take L-tyrosine at the same time as levodopa/carbidopa. Separate high-dose tyrosine from levodopa by at least 2 hours, and stop the supplement if you notice more wearing off, delayed on, nausea, or dyskinesia. Keep your levodopa schedule consistent and tell your prescriber before using tyrosine daily.

ModerateCaution

Green Tea Extract

Green tea extract can contain concentrated EGCG and other catechins that inhibit catechol-O-methyltransferase in preclinical levodopa models. That could theoretically change levodopa methylation and exposure, especially with high-dose extracts rather than ordinary brewed tea. Human clinical interaction data are limited, so the main concern is new dyskinesia, nausea, insomnia, or motor fluctuation after starting a concentrated extract.

Recommendation: Avoid high-dose green tea extract unless your prescriber knows you take levodopa/carbidopa. If you use it, keep the dose consistent and watch for dyskinesia, nausea, palpitations, insomnia, or changes in wearing off. Ordinary dietary green tea is less concerning than concentrated EGCG products.

SeriousTiming Sensitive

BCAAs

BCAA supplements can reduce or delay levodopa's benefit because branched-chain amino acids compete with levodopa for the same intestinal and blood-brain barrier transport pathways. This can make Parkinson's symptoms break through sooner, especially in people who already notice protein-sensitive wearing off. The risk is highest when BCAAs are taken close to a levodopa dose or repeatedly during the daytime dosing window.

Recommendation: Do not take BCAAs with levodopa/carbidopa doses. Take levodopa at least 30-60 minutes before amino acid or protein supplements, and keep BCAAs at least 2 hours away from levodopa when possible. If your mobility worsens after starting BCAAs, stop the supplement and review your levodopa schedule with your prescriber.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

4

Randomized controlled trials

1
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Levodopa/Carbidopa in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.